Header Logo

Connection

Karen Beckman to Humans

This is a "connection" page, showing publications Karen Beckman has written about Humans.
Connection Strength

0.178
  1. Brugada pattern mimicking acute coronary syndrome in a febrile state. J Okla State Med Assoc. 2012 Jul; 105(7):275-8.
    View in: PubMed
    Score: 0.023
  2. Giant right atrial diverticulum associated with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 2006 Apr; 17(4):443.
    View in: PubMed
    Score: 0.015
  3. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol. 2002 Feb; 13(2):144-50.
    View in: PubMed
    Score: 0.011
  4. Unexpectedly high defibrillation thresholds in an active can implantable cardioverter defibrillator system. Pacing Clin Electrophysiol. 2001 Jul; 24(7):1168-9.
    View in: PubMed
    Score: 0.011
  5. Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway: Role of the Resetting Response to Select the Ablation Target. Circ Arrhythm Electrophysiol. 2018 09; 11(9):e006631.
    View in: PubMed
    Score: 0.009
  6. Images in clinical medicine. Amiodarone-induced skin discoloration. N Engl J Med. 1997 Dec 18; 337(25):1813.
    View in: PubMed
    Score: 0.008
  7. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial. J Am Coll Cardiol. 2016 Feb 16; 67(6):674-683.
    View in: PubMed
    Score: 0.007
  8. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):113-9.
    View in: PubMed
    Score: 0.006
  9. The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1990 Mar 01; 15(3):640-7.
    View in: PubMed
    Score: 0.005
  10. Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: techniques for assessing conduction block across surgical lesions. Heart Rhythm. 2009 Dec; 6(12 Suppl):S50-63.
    View in: PubMed
    Score: 0.005
  11. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization : a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):E1-24.
    View in: PubMed
    Score: 0.005
  12. Spontaneous pulmonary vein firing in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol. 2007 Sep; 18(10):1067-75.
    View in: PubMed
    Score: 0.004
  13. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):136-44.
    View in: PubMed
    Score: 0.004
  14. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005 Apr; 149(4):657-63.
    View in: PubMed
    Score: 0.004
  15. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm. 2004 Dec; 1(6):669-75.
    View in: PubMed
    Score: 0.003
  16. Relation between pulmonary vein firing and extent of left atrial-pulmonary vein connection in patients with atrial fibrillation. Circulation. 2004 Mar 30; 109(12):1523-9.
    View in: PubMed
    Score: 0.003
  17. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003 Sep; 14(9):940-8.
    View in: PubMed
    Score: 0.003
  18. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol. 2003 Apr 01; 91(7):812-6.
    View in: PubMed
    Score: 0.003
  19. Coronary sinus-ventricular accessory connections producing posteroseptal and left posterior accessory pathways: incidence and electrophysiological identification. Circulation. 2002 Sep 10; 106(11):1362-7.
    View in: PubMed
    Score: 0.003
  20. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol. 2001 Nov 15; 38(6):1718-24.
    View in: PubMed
    Score: 0.003
  21. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001 Sep; 12(9):996-1001.
    View in: PubMed
    Score: 0.003
  22. Reversing the direction of paced ventricular and atrial wavefronts reveals an oblique course in accessory AV pathways and improves localization for catheter ablation. Circulation. 2001 Jul 31; 104(5):550-6.
    View in: PubMed
    Score: 0.003
  23. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001 Apr 24; 103(16):2066-71.
    View in: PubMed
    Score: 0.003
  24. Transseptal left heart catheterization for cardiac ablation procedures. J Interv Card Electrophysiol. 2001 Mar; 5(1):89-95.
    View in: PubMed
    Score: 0.003
  25. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation. 2001 Feb 06; 103(5):699-709.
    View in: PubMed
    Score: 0.003
  26. Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structural heart disease, and inducible ventricular tachycardia at electrophysiologic study. Clin Cardiol. 2000 Mar; 23(3):195-200.
    View in: PubMed
    Score: 0.002
  27. Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 1998 Jan; 9(1):2-12.
    View in: PubMed
    Score: 0.002
  28. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function. Am J Cardiol. 1997 Aug 15; 80(4):458-63.
    View in: PubMed
    Score: 0.002
  29. Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation. 1996 Sep 01; 94(5):1027-35.
    View in: PubMed
    Score: 0.002
  30. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation. 1996 Aug 01; 94(3):407-24.
    View in: PubMed
    Score: 0.002
  31. Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation. 1994 Jun; 89(6):2655-66.
    View in: PubMed
    Score: 0.002
  32. Late potentials are unaffected by radiofrequency catheter ablation in patients with ventricular tachycardia. Pacing Clin Electrophysiol. 1994 Feb; 17(2):157-65.
    View in: PubMed
    Score: 0.002
  33. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation. 1993 Dec; 88(6):2607-17.
    View in: PubMed
    Score: 0.002
  34. A functional approach to the preexcitation syndromes. Cardiol Clin. 1993 Feb; 11(1):121-49.
    View in: PubMed
    Score: 0.002
  35. Model-based rhythm analysis of the ECG. Evaluation of a prototype implementation. J Electrocardiol. 1993; 26 Suppl:182-93.
    View in: PubMed
    Score: 0.002
  36. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992 07 30; 327(5):313-8.
    View in: PubMed
    Score: 0.001
  37. Localization and radiofrequency catheter ablation of accessory AV pathways in Wolff-Parkinson-White syndrome. J Electrocardiol. 1992; 24 Suppl:24.
    View in: PubMed
    Score: 0.001
  38. Factors associated with recurrence of accessory pathway conduction after radiofrequency catheter ablation. Pacing Clin Electrophysiol. 1991 Nov; 14(11 Pt 2):2042-8.
    View in: PubMed
    Score: 0.001
  39. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991 Jun 06; 324(23):1605-11.
    View in: PubMed
    Score: 0.001
  40. Long-term follow-up in patients with incessant ventricular tachycardia. Am J Cardiol. 1990 Oct 01; 66(10):831-6.
    View in: PubMed
    Score: 0.001
  41. A simple method of monitoring antiarrhythmic drugs during short- and long-term therapy. Am J Cardiol. 1989 May 15; 63(17):1273-5.
    View in: PubMed
    Score: 0.001
  42. Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing. Pacing Clin Electrophysiol. 1988 Apr; 11(4):434-44.
    View in: PubMed
    Score: 0.001
  43. Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome. Am Heart J. 1987 Dec; 114(6):1436-44.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.